DMK Pharmaceuticals Corporation

LSE:0A4X Stock Report

Market Cap: US$10.0

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DMK Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Eddie Glover

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Eddie Glover (74 yo)

no data

Tenure

Mr. Eddie Wabern Glover serves as Chief Executive Officer of US Compounding Inc at DMK Pharmaceuticals Corporation (formerly known as Adamis Pharmaceuticals Corporation). He co-founded US Compounding, Inc....